---
ticker: "PPH"
name: "VanEck Pharmaceutical ETF"
url: "https://etf.net/etf/PPH"
grade: "A"
score: 73
graded_at: "2026-10-12"
category: "Pharma & Therapeutics"
category_rank: "1 of 9"
methodology: "https://etf.net/methodology"
---

# PPH: VanEck Pharmaceutical ETF

Grade **A**, Score 73 of 100. Rank 1 of 9 in Pharma & Therapeutics.

Graded Oct 12, 2026.

## Grade pillars

| Pillar | Score | Category rank |
| --- | --- | --- |
| Cost | 79 | 2 of 9 |
| Mission | 80 | 1 of 6 |
| Risk | 57 | 4 of 9 |
| Tradability | 94 | 1 of 9 |
| Holdings | 39 | 7 of 9 |
| Durability | 73 | 3 of 9 |

## Top holdings

The fund holds 27 positions. These are the largest 27, by weight.

| # | Ticker | Name | Weight |
| --- | --- | --- | --- |
| 1 | LLY | Eli Lilly & Co | 20.88% |
| 2 | MRK | Merck & Co Inc | 13.21% |
| 3 | NVO | Novo Nordisk A/S | 5.65% |
| 4 | PFE | Pfizer Inc | 5.06% |
| 5 | TEVA | Teva Pharmaceutical Industries Ltd | 4.88% |
| 6 | MCK | Mckesson Corp | 4.71% |
| 7 | BMY | Bristol-Myers Squibb Co | 4.57% |
| 8 | COR | Cencora Inc | 4.49% |
| 9 | GSK | Gsk Plc | 4.28% |
| 10 | ABBV | Abbvie Inc | 3.79% |
| 11 | HLN | Haleon Plc | 3.78% |
| 12 | NVS | Novartis Ag | 3.60% |
| 13 | AZN | Astrazeneca Plc | 3.49% |
| 14 | JNJ | Johnson & Johnson | 3.37% |
| 15 | SNY | Sanofi Sa/France | 3.22% |
| 16 | TAK | Takeda Pharmaceutical Co Ltd | 2.76% |
| 17 | ZTS | Zoetis Inc | 2.62% |
| 18 | VTRS | Viatris Inc | 1.48% |
| 19 | JAZZ | Jazz Pharmaceuticals Plc | 1.23% |
| 20 | CORT | Corcept Therapeutics Inc | 0.80% |
| 21 | AXSM | Axsome Therapeutics Inc | 0.66% |
| 22 | ELAN | Elanco Animal Health Inc | 0.50% |
| 23 | DFTX | Definium Therapeutics Inc | 0.47% |
| 24 | OGN | Organon & Co | 0.29% |
| 25 | PRGO | Perrigo Co Plc | 0.11% |
| 26 | — | Other/Cash | 0.08% |
| 27 | — | -Usd Cash- | <0.01% |

Source: etf.net, https://etf.net/etf/PPH. Please cite the page URL.